Pathology
Consensus report on anatomy, pathophysiology and clinical significance of the gastro-esophageal junction.
23 Jun, 2022 | 10:26h | UTC
Causes of liver cancer are changing around the world: some up, some down.
13 Jun, 2022 | 07:54h | UTCNews Release: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down – UC San Diego Health
Original Study: Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer – Cell Metabolism (link to abstract – $ for full-text)
Circulating tumor DNA as a biomarker in patients with stage III and IV Wilms tumor.
8 Jun, 2022 | 10:43h | UTCCommentary: Analysis of Circulating Tumor DNA as a Biomarker in Stage III and IV Wilms Tumor – The ASCO Post
#ASCO22 – RCT: Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer.
6 Jun, 2022 | 11:53h | UTCCirculating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: ctDNA Effectively Detects When Adjuvant Chemo Is Avoidable in Stage II Colon Cancers – Cancer Network
Commentary on Twitter
DYNAMIC: Among patients with stage II colon cancer, a ctDNA-guided management approach reduced the use of adjuvant chemotherapy without increasing the risk of recurrence. #ASCO22 https://t.co/xXjXyPXRC9 pic.twitter.com/gvHMnGWbyE
— NEJM (@NEJM) June 4, 2022
Review: Pathogenesis of alcohol-associated liver disease.
6 Jun, 2022 | 10:50h | UTCPathogenesis of Alcohol-Associated Liver Disease – Journal of Clinical and Experimental Hepatology
Cardiac metastasis from solid cancers: a 35-year single-center autopsy study.
3 Jun, 2022 | 10:54h | UTC
RCT: Effect of reflectance confocal microscopy for suspect lesions on diagnostic accuracy in melanoma.
2 Jun, 2022 | 10:41h | UTC
Commentary on Twitter
In this RCT, adjunctive use of reflectance confocal microscopy for suspicious lesions is proven to reduce unnecessary excisions and removes all aggressive melanomas at baseline in a real-life, prospective clinical decision making setting. https://t.co/cWJu9TlaEH
— JAMA Dermatology (@JAMADerm) June 1, 2022
M-A: Association between benign ovarian tumors and ovarian cancer risk.
2 Jun, 2022 | 10:18h | UTC
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
31 May, 2022 | 10:46h | UTC
Commentary on Twitter
Online Now: Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies https://t.co/Im8F60VMjO
— Cancer Cell (@Cancer_Cell) May 27, 2022
A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions.
30 May, 2022 | 11:29h | UTC
Commentary on Twitter
New in @AGA_Gastro: 1️⃣st ever severity index for eosinophilic esophagitis (#EoE)! We can now combine all elements of a patient’s disease activity into a single score to understand disease severity. Check it out ➡️ https://t.co/WgRiH47S6W @KhouryMD @LabMuir @DrGaryFalk #DDW2022 pic.twitter.com/Tyo6hltJ5r
— American Gastroenterological Association (AGA) (@AmerGastroAssn) May 20, 2022
Retrospective Cohort Study | Ovarian cancer detection in average-risk women: classic- versus nonclassic-appearing adnexal lesions.
30 May, 2022 | 10:58h | UTCNews Release: Researchers use ultrasound to predict ovarian cancer – Radiological Society of North America
Commentary: Appearance of Ovarian Lesions on Ultrasound May Predict Malignancy – HealthDay
Commentary on Twitter
Classifying adnexal lesion appearance as classic or nonclassic has high sensitivity and specificity for diagnosing malignancy in women at average risk for ovarian cancer. @BaranLab @drantil7 @kpatellippmann @katematuren @ayakamaya @hanna_zrad @LizSadowski https://t.co/6NphOIycMe pic.twitter.com/99DyWIHXwU
— Radiology (@radiology_rsna) March 28, 2022
Review: Autopsy in the era of advanced cardiovascular imaging.
30 May, 2022 | 10:49h | UTCAutopsy in the era of advanced cardiovascular imaging – European Heart Journal
Commentary on Twitter
Autopsy in the era of advanced cardiovascular imaging https://t.co/2sFRlhQ9Fh @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/gJthaYph4M
— European Society of Cardiology Journals (@ESC_Journals) May 24, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Health Technology Assessment: Molecular testing for thyroid nodules of indeterminate cytology.
25 May, 2022 | 10:42h | UTC
Nonrandomized Controlled Trial: Clinical impact of intraoperative margin assessment in breast-conserving surgery with a novel Pegulicianine Fluorescence–guided system.
18 May, 2022 | 10:28h | UTC
Commentary on Twitter
New intraoperative margin detection technology is safe and reduces reexcision rates in patients undergoing breast conserving surgery! (include infographic) #bcsm https://t.co/NqUOhGJBo4
— JAMA Surgery (@JAMASurgery) May 11, 2022
Interstitial lung disease in infancy and early childhood: a clinicopathological primer.
12 May, 2022 | 07:54h | UTC
Atherosclerosis: Recent developments.
3 May, 2022 | 11:03h | UTCAtherosclerosis: Recent developments – Cell
Commentary on Twitter
We've learned a lot about atherosclerosis in recent years, including new genomic underpinnings, role of aging, clonal hematopoiesis, and the gut microbiome. A new, excellent review covers all of the progress and the many residual questionshttps://t.co/nF59sqiB6P @CellCellPress pic.twitter.com/oXVzf4J5XT
— Eric Topol (@EricTopol) May 2, 2022
Under a CC BY 4.0 license
Review: Germline testing and genetic counselling in prostate cancer.
28 Apr, 2022 | 08:11h | UTCGermline testing and genetic counselling in prostate cancer – Nature Reviews Urology (if the link is paywalled, try this one at PMC)
ASCO Guideline Update: biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer.
20 Apr, 2022 | 09:47h | UTC
Safety and economic analysis of selective histopathology following cholecystectomy: multicenter, prospective, cross-sectional study.
30 Mar, 2022 | 09:59h | UTC
Commentary on Twitter
Open Access in the April BJS: Safety and economic analysis of selective histopathology following cholecystectomy: FANCY study https://t.co/3qUVzf6Xwu @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/dtFJpVJkke
— BJS (@BJSurgery) March 28, 2022
Review | Imaging findings of malignant skin tumors: radiological–pathological correlation.
25 Mar, 2022 | 08:40h | UTC
M-A: Site-specific therapy in cancers of unknown primary site.
8 Mar, 2022 | 08:23h | UTC
Systematic Review: Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
8 Mar, 2022 | 08:24h | UTC
A review of mucinous cystic and intraductal neoplasms of the pancreatobiliary tract: recent advances.
24 Feb, 2022 | 09:59h | UTC
Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
21 Feb, 2022 | 08:47h | UTC
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
16 Jan, 2022 | 22:41h | UTCCommentary: Large international evaluation shows AI accurately diagnoses prostate cancer – Karolinska Institutet
Commentary from one of the authors on Twitter (thread – click for more)
Honored to be part of the recently published study in Nature Medicine on the global #AI competition PANDA as a member of the @Google team and an expert panel of 6 US and Canadian Uropathologists. Check out this thread for my 5 top takeaways 👇#pathology #PathTwitter
— Dr. Mahul Amin (@DrMahul) January 14, 2022